Reveal Genomics' TNBCDX predicted response rates and risk of relapse for patients on anthracycline-free neoadjuvant therapy in a retrospective validation study.
Cancer Centers Look to New NGS-Based 'Frankenpanel' to Get Fast Info on Clinically Actionable Genes
Premium
Memorial Sloan Kettering Cancer Center is among the first healthcare systems to implement the rapid sequencing assay, which can consolidate single-gene tests.
Exact Sciences Blood-Based Colon Cancer Screening Data at ESMO Exceeds Expectations
Although the results were better than expected, the company cautioned that it expects lower performance in its prospective trial readout, planned for early next year.
Proteomics Firm Nomic Bio Closes $42M Series B Round
The Montreal-based company said it will use the funds to expand its commercial operations and advance its nELISA protein profiling platform.
Colorectal Cancer Functional Study Leads to Causal Variants, Gene Targets
Researchers relied on fine-mapping, epigenetic insights, and reporter assays to prioritize causal variants from past GWAS, linking them to new and known target genes.